World's Smallest & Lightest Artificial Heart Assist Device

Witness the world’s smallest and lightest artificial heart assist device in action—spanning from China to Indonesia, Thailand, and beyond.

This breakthrough in mechanical circulatory support represents a new generation of LVAD technology, engineered to deliver powerful cardiac assistance in a remarkably compact and lightweight form. Designed to support patients with advanced heart failure, it offers the potential for greater mobility, improved comfort, and enhanced quality of life.

From early clinical adoption in China to real-world implementation across Southeast Asia and on the global stage, this innovation is changing what is possible in heart assist therapy—bringing advanced care closer to patients, wherever they are in the world.

Some Benefits of the World’s Smallest & Lightest Artificial Heart Assist Device

Small-sized and lightweight compared to dominant US-made devices. The diameter is reduced by 40%, and the weight is reduced by 50%.

Implantation surgery is less invasive.

Low power consumption of up to 33 hours, with long endurance and a 50% reduction in the weight of peripherals.

Implantation surgery is less invasive.

Low power consumption of up to 33 hours, with long endurance and a 50% reduction in the weight of peripherals.

Fewer infections with extra long durability; both percutaneous cable infection and severe infection have been reported as 0 case in clinical trial.

Better hemocompatibility with faster recovery of patients compared to similar LVADs.

Fewer infections with extra long durability; both percutaneous cable infection and severe infection have been reported as 0 case in clinical trial.

Better hemocompatibility with faster recovery of patients compared to similar LVADs.

HeartSpan.ai, In Collaboration with RSCM, Leads Indonesia's first Successful Implantation of the World's Smallest and Lightest Artificial Heart Assist Device

An unprecedented initiative supported by the convergence of advanced medtech, medical knowledge sharing cloud and agentic AI heralds a new heart failure management solution for more than 10 million heart failure patients in Indonesia

Watch this video of the trainings and other events leading up to the successful implantation: 

Looking for Advance LVAD Solutions?

Let us know how we can help you whether you are a healthcare consumer looking for heart longevity, artificial heart assist implant device solutions, post-surgery care support.
Are you a patient interested to register for the LVAD program in Indonesia?
Are you a hospital in Indonesia interested in LVAD support?

See What's Happening in
Indonesia, Thailand and Other Countries Soon!

See our LVAD program in Thailand!

Connect with us on

HeartSpan.ai is the cardiovascular longevity division of Borderless Healthcare Group. All rights reserved. Copyright 2026.
error: